In the circulation of patients with COVID-19, IL-6 reaches its peak at advanced stages, on average after the second week of disease, and, notably, this increase is accompanied by peak concentrations of IL-10 and CRP (11, 13). This evidence concerns the gene IL6 and COVID-19.